Edwards Lifesciences Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
Go back to Edwards Lifesciences Reports Third Quarter Results
October 27, 2015 10:50 AM EDT
Canaccord Genuity reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $180.00 (from $178.00), following the company's 3Q earnings results. EW reported EPS of $1.07, beating consensus by 9c. Management does an excellent job hedging FX swings to neutralize EPS... More
October 27, 2015 8:57 AM EDT
UBS reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $203.00 (from $201.00), following the company's 3Q15 earnings results. Management upped fullyear EPS guidance by $4.43-4.53 from $4.30-4.40, which assumes a touch more upside in Q4.
Analyst Matt Miksic... More
October 26, 2015 4:18 PM EDT
Edwards Lifesciences (NYSE: EW) reported Q3 EPS of $1.07, $0.09 better than the analyst estimate of $0.98. Revenue for the quarter came in at $615 million versus the consensus estimate of $598.29 million.
Edwards Lifesciences sees FY2015 EPS of $4.43-$4.53, versus the consensus of $4.37. Edwards Lifesciences sees FY2015... More
